Celerion

Celerion is a leading company in the field of early clinical research, operating as a private corporation headquartered in Lincoln, Nebraska. With a workforce of 939 employees, Celerion generates an impressive $1,000 million in annual revenue. Celerion specializes in Applied Translational Medicine, bridging the gap between research discoveries and their practical application in human drug development. They offer a comprehensive suite of services, including First-in-Human studies, clinical proof-of-concept trials, cardiovascular safety assessments (TQT, robust QT), ADME evaluations, and NDA-enabling clinical pharmacology studies. Their expertise extends to modeling and simulation, study design, medical writing, clinical data sciences, biostatistics, and PK/PD analysis. Celerion also provides bioanalytical assays for both small and large molecules throughout the clinical drug development process. They further support their clients with regulatory, drug development, and program management services. For inquiries or further details, please visit Celerion's website at www.celerion.com.